OCS-01: A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery (clinicaltrials.gov) - Apr 29, 2022 - P3 | N=240 | Not yet recruiting | Sponsor: Oculis | Trial completion date: Dec 2022 ➔ Jun 2023 | Initiation date: Jan 2022 ➔ May 2022 | Trial primary completion date: Sep 2022 ➔ Mar 2023
Trial completion date • Trial initiation date • Trial primary completion date • Cataract • Immunology • Inflammation • Ocular Inflammation • Ophthalmology • Pain
|